Androutsellis-Theotokis A, Ghassemi F, Rudnick G
Department of Pharmacology, Yale University, New Haven, Connecticut 06520-8066, USA.
J Biol Chem. 2001 Dec 7;276(49):45933-8. doi: 10.1074/jbc.M107462200.
Serotonin transporter (SERT) contains a single reactive external cysteine residue at position 109 (Chen, J. G., Liu-Chen, S., and Rudnick, G. (1997) Biochemistry 36, 1479-1486) and seven predicted cytoplasmic cysteines. A mutant of rat SERT (X8C) in which those eight cysteine residues were replaced by other amino acids retained approximately 32% of wild type transport activity and approximately 56% of wild type binding activity. In contrast to wild-type SERT or the C109A mutant, X8C was resistant to inhibition of high affinity cocaine analog binding by the cysteine reagent 2-(aminoethyl)methanethiosulfonate hydrobromide (MTSEA) in membrane preparations from transfected cells. Each predicted cytoplasmic cysteine residue was reintroduced, one at a time, into the X8C template. Reintroduction of Cys-357, located in the third intracellular loop, restored MTSEA sensitivity similar to that of C109A. Replacement of only Cys-109 and Cys-357 was sufficient to prevent MTSEA sensitivity. Thus, Cys-357 was the sole cytoplasmic determinant of MTSEA sensitivity in SERT. Both serotonin and cocaine protected SERT from inactivation by MTSEA at Cys-357. This protection was apparently mediated through a conformational change following ligand binding. Although both ligands bind in the absence of Na(+) and at 4 degrees C, their ability to protect Cys-357 required Na(+) and was prevented at 4 degrees C. The accessibility of Cys-357 to MTSEA inactivation was increased by monovalent cations. The K(+) ion, which is believed to serve as a countertransport substrate for SERT, was the most effective ion for increasing Cys-357 reactivity.
血清素转运体(SERT)在第109位含有一个单一的反应性外部半胱氨酸残基(Chen, J. G., Liu-Chen, S., and Rudnick, G. (1997) Biochemistry 36, 1479 - 1486)以及七个预测的胞质半胱氨酸。大鼠SERT的一个突变体(X8C),其中这八个半胱氨酸残基被其他氨基酸取代,保留了约32%的野生型转运活性和约56%的野生型结合活性。与野生型SERT或C109A突变体不同,X8C对来自转染细胞的膜制剂中半胱氨酸试剂氢溴酸2 -(氨基乙基)甲硫基磺酸盐(MTSEA)抑制高亲和力可卡因类似物结合具有抗性。将每个预测的胞质半胱氨酸残基一次一个地重新引入到X8C模板中。位于第三个细胞内环的Cys - 357的重新引入恢复了与C109A相似的MTSEA敏感性。仅替换Cys - 109和Cys - 357就足以防止MTSEA敏感性。因此,Cys - 357是SERT中MTSEA敏感性的唯一胞质决定因素。血清素和可卡因都能保护SERT在Cys - 357处不被MTSEA灭活。这种保护显然是通过配体结合后的构象变化介导的。尽管两种配体在没有Na(+)和4℃时结合,但它们保护Cys - 357的能力需要Na(+)并且在4℃时被阻止。单价阳离子增加了Cys - 357对MTSEA灭活的可及性。据信作为SERT反向转运底物的K(+)离子是增加Cys - 357反应性最有效的离子。